Optical coherence tomography grading reproducibility during the comparison of age-related macular degeneration treatments trials

Ophthalmology

Volumn 119, Issue 12, 2012, Pages 2549-2557

  Decroos, Francis Char ^a,b   Toth, Cynthia A ^b   Stinnett, Sandra S ^b   Heydary, Cynthia S ^b   Burns, Russell ^b   Jaffe, Glenn J ^a  

^a WILLS EYE HOSPITAL   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ARTICLE; CLINICAL TRIAL; CORRELATION COEFFICIENT; HUMAN; IMAGE ANALYSIS; INTRARETINAL FLUID; KAPPA STATISTICS; LONGITUDINAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; REPRODUCIBILITY; RETINA EDEMA; RETINA FOVEA THICKNESS; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID; SUBRETINAL PIGMENT EPITHELIUM FLUID; TREATMENT RESPONSE; VISUAL SYSTEM PARAMETERS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DOUBLE-BLIND METHOD; EPIRETINAL MEMBRANE; HUMANS; MACULAR DEGENERATION; OBSERVER VARIATION; PROSPECTIVE STUDIES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RETINA; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84870673826     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.06.040     Document Type: Article

References (33)

1. D.F. Martin, M.G. Maguire, G.S. Ying Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
2. M.R. Hee, C.R. Baumal, C.A. Puliafito Optical coherence tomography of age-related macular degeneration and choroidal neovascularization Ophthalmology 103 1996 1260 1270
3. G.J. Jaffe, J. Caprioli Optical coherence tomography to detect and manage retinal disease and glaucoma Am J Ophthalmol 137 2004 156 169
4. T.D. Ting, M. Oh, T.A. Cox Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration Arch Ophthalmol 120 2002 731 737
5. M.R. Hee, C.A. Puliafito, C. Wong Quantitative assessment of macular edema with optical coherence tomography Arch Ophthalmol 113 1995 1019 1029
6. A.H. Rogers, A. Martidis, P.B. Greenberg, C.A. Puliafito Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization Am J Ophthalmol 134 2002 566 576
7. P.K. Kaiser, B.A. Blodi, H. Shapiro, N.R. Acharya Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2007 1868 1875
8. R.L. Avery, D.J. Pieramici, M.D. Rabena Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 2006 363 372 e5
9. R.M. Rich, P.J. Rosenfeld, C.A. Puliafito Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Retina 26 2006 495 511
10. O.P. Gupta, G. Shienbaum, A.H. Patel A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact Ophthalmology 117 2010 2134 2140
11. H. Dadgostar, A.A. Ventura, J.Y. Chung Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration Ophthalmology 116 2009 1740 1747
12. S.P. Rothenbuehler, D. Waeber, C.K. Brinkmann Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration Am J Ophthalmol 147 2009 831 837
13. A.E. Fung, G.A. Lalwani, P.J. Rosenfeld An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 2007 566 583
14. G.G. Koch, J.R. Landis, J.L. Freeman A general methodology for the analysis of experiments with repeated measurement of categorical data Biometrics 33 1977 133 158
15. J.R. Landis, G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
16. N. Zhang, G.C. Hoffmeyer, E.S. Young Optical coherence tomography reader agreement in neovascular age-related macular degeneration Am J Ophthalmol 144 2007 37 44
17. I. Krebs, S. Hagen, W. Brannath Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration Ophthalmology 117 2010 1577 1584
18. A. Domalpally, B.A. Blodi, I.U. Scott The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4 Arch Ophthalmol 127 2009 1461 1467
19. M. Ritter, J. Elledge, C. Simader Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres Br J Ophthalmol 95 2011 381 385
20. A.R. Glassman, R.W. Beck, D.J. Browning Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective Invest Ophthalmol Vis Sci 50 2009 560 566
21. J.A. Haller, F. Bandello, R. Belfort Jr Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146 e3
22. D.M. Brown, P.A. Campochiaro, R.P. Singh Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133 e1
23. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology 98 1991 786 806
24. C. Ahlers, S. Michels, H. Elsner Topographic angiography and optical coherence tomography: a correlation of imaging characteristics Eur J Ophthalmol 15 2005 774 781
25. F. Coscas, G. Coscas, E. Souied Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration Am J Ophthalmol 144 2007 592 599
26. J.R. Wilkins, C.A. Puliafito, M.R. Hee Characterization of epiretinal membranes using optical coherence tomography Ophthalmology 103 1996 2142 2151
27. C.I. Falkner-Radler, C. Glittenberg, S. Hagen Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery Ophthalmology 117 2010 798 805
28. A.R. Feinstein, D.V. Cicchetti High agreement but low kappa: I The problems of two paradoxes J Clin Epidemiol 43 1990 543 549
29. P.E. Crewson Reader agreement studies AJR Am J Roentgenol 184 2005 1391 1397
30. V.J. Srinivasan, M. Wojtkowski, A.J. Witkin High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography Ophthalmology 113 2006 2054 e1-14
31. M. Wojtkowski, T. Bajraszewski, I. Gorczynska Ophthalmic imaging by spectral optical coherence tomography Am J Ophthalmol 138 2004 412 419
32. P.A. Keane, R.A. Bhatti, J.W. Brubaker Comparison of clinically relevant findings from high-speed Fourier-domain and conventional time-domain optical coherence tomography Am J Ophthalmol 148 2009 242 248 e1
33. K. Sayanagi, S. Sharma, T. Yamamoto, P.K. Kaiser Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab Ophthalmology 116 2009 947 955